Founded in 2012 Skin Analytics is a research-led company committed to helping more people to survive skin cancer.
Skin Analytics have provided teledermatology services for over 5 years and our AI-supported teledermatology service since April 2020. We have spent considerable time working with General Practitioners in Primary Care, Dermatologists, Hospital Providers and leading researchers to ensure that our services and DERM have real clinical utility.
Meet The Team
Dr Helen Marsden
Clinical Research Director
Helen has 17 years of clinical research experience in both corporate and academic settings delivering clinical trials and data generation. She has authored seven peer-reviewed journals. Helen has a PhD in medical microbiology from Leeds University.
Dr Jack Greenhalgh
Jack joined Skin Analytics having worked in computer vision and machine learning in both industry and academia for many years. He holds an MEng in Computer Systems Engineering from the University of Sussex and a Ph.D. in Computer Science from the University of Bristol.
David has 12 years of experience in Accounting, Finance and Operations in professional services, start-ups and FCA regulated lending. David is a Chartered Accountant (ICAEW) and has a BA in Geography from Oxford.
Dr Dan Mullarkey
Dan is a practicing GP who has experience working within the AI & Digital Health settings. He sees the adoption of digital health technologies as key in helping healthcare services to evolve to offering support & efficiency improvements and optimise patient experience. Dan holds degrees in Medicine (BMBS) and Biomedical Sciences (BMedSci) from the University of Nottingham.
Director of Business Development
Sarah joined Skin Analytics after a career in Enterprise Software, working across client management and business development in the US and the UK. At Skin Analytics, Sarah is responsible for building successful partnerships with the public and private sector.
Jim has been working in technology for the last 20 years and is an experienced software engineer and technical architect. He joined the Skin Analytics team after a 10 year position as CTO of a digital agency in London.
Quality and Regulatory Director
James has over 12 years experience in medical device regulatory and quality affairs with large and small medtech companies across multiple geographies, including UK, USA and Japan. He has a keen interest in software as a medical device and is excited about the future of AI in medical applications.
Fin shapes and drives the product roadmap for Skin Analytics, focusing on evolving our service to deliver ever better value and experience for our growing client base and the patients they serve. His background is in technology innovation and systems delivery, with significant experience in the NHS including electronic prescriptions and electronic referral. Fin holds a BA (hons) and MEng from Cambridge University.
Tim has been involved with Skin Analytics since it started in 2012. He has a background in human resources, customer experience improvement and business development. Tim holds an MBA from the Australian Institute of Business.
Business Development Manager
Rachael is an experienced commercial partnerships manager, who has worked with primary and secondary care organisations, to redesign service pathways in order to deliver better patient care that is sustainable for the NHS.
Dr Jenny Dean
Clinical Safety Director
Jenny has over 20 years experience in healthcare including 10 years as a doctor and 6 years as the Medical Director of Health IT companies. Her focus is on the clinical safety and usability of software solutions for clinician and patients. Jenny holds degrees in Medicine (MB ChB), an MSc in remote healthcare, and an MBA.
Chair, Non Executive Director, Advisor
Dominic was Managing Partner of Marakon Associates, a US-domiciled strategy consulting firm, where he worked for 15 years advising chief executives of plcs on growing long term value.
Since leaving Marakon he has worked as a chair, non executive director and advisor in the private, public and charity sectors, specialising in growth, turnaround and governance mainly in healthcare and financial services.
He is currently chair of two NHS trusts, the Royal Free London NHS Foundation Trust and the Royal National Orthopaedic Hospital NHS Trust. He is also a director of UCL Partners, the academic health science partnership and a trustee of health think tank The King’s Fund.
Juan Pane Arregui
Entrepreneur and Business Angel
Juan spent 9 years working in software development at companies in Argentina and Spain and developed an anti virus in his free time. In 1995, he started Media Net Software and sold the company after 20 years while it was employing 200+ engineers in Spain, Mexico and the USA. From 1998 to 2004 Juan managed the digitizing projects for Diario El País and Diario El Mundo through a corporate venture we created ad-hoc, where they hired a team of 70+ professionals.
He is Current owner of Evoluciona, a digital interactive agency. He was the CEO from 2005 to 2013 and saw the company grow to work with blue chip companies such as Microsoft, BBVA, Acciona, RTVE, FOX or El Corte Inglés.
In 2005 he co-founded BuyVIP with two other partners. This e-commerce site grew to 100+ employees in five years and was operating in Germany, Italy, Spain, Portugal, Austria, Poland and The Netherlands. BuyVIP was sold to Amazon in 2010. In 2009 Juan co-founded Tech on Rails, an engineering services company specialized in high-speed trains and aeronautics.
Juan is an investor, advisor and/or board member at several companies and is always open to new opportunities where business strategy, processes or technology can be applied to move companies to the next stage.
Chairman of Polar Light Ventures Ltd and Investor
Previously he was the Managing Director of Dhabi Holdings PJSC, the investment company of senior members of the ruling family of Abu Dhabi. Michael Buchen joined Dhabi Holdings from Mubadala Development Company PJSC where he worked in the Special Situations Team. Before Mubadala, he worked for Roland Berger Strategy Consultants in Europe, China and the Middle East. Michael currently serves or previously served on the Board of directors and Advisory Boards of a number of companies in the Venture Capital, Tech, Financial Services, Food & Beverage, Energy and Telecom sector.
He holds a Master of Science in Business Management from the University of Muenster in Germany.
Partner at Hoxton Ventures
He currently represents Hoxton on the boards of Biotx, Fy!, Giraffe360, Kbox Global, Raptor Supplies, Skin Analytics, SOC.OS, TourRadar, XYZ Reality and Yieldify, and serves as a board observer on Behavox, Darktrace, Finesse, Karakuri, Loveshark, Panakeia and Vidya Health. He previously served on the boards of Babylon Health, bd4travel (acquired by Dnata), Campanja (acquired by 24/7 Media) and Deliveroo.
Hussein also serves on the board of Tech Nation. He also sits on the advisory board of GTO Partners, a tech mid-market buyout firm, and Landscape, a venture capital review site. While forming Hoxton, he helped Eros STX Global develop ErosNow, an online streaming video platform for Bollywood.
Prior to Hoxton, Hussein was an associate with Accel Partners. He joined Accel from Microsoft Corporation. Earlier in his career, he worked with three startups, Safe-View (acquired by L-3), Radiance Technologies (acquired by Comcast) and Studio Verso (acquired by KPMG).
Hussein holds an MBA from London Business School and did his undergraduate studies in Symbolic Systems at Stanford University. He stubbornly refuses to swear allegiance to a monarch and remains a proud American.